|
|||||
|
|
Effect of switching to teneligliptin from other dipeptidyl peptidase‐4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease |
|
| Authors: | Munehiro Kitada Yoshio Ogura Kyoko Nitta Mizue Fujii Keizo Kanasaki Kazunori Konishi Yasuo Iida Atsushi Nakagawa Daisuke Koya |
| Abstract: | |
| Keywords: | Diabetic kidney disease Plasma DPP‐4 activity Teneligliptin |